Disciplined Investments’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13
Closed -$773 1136
2023
Q2
$773 Sell
13
-1
-7% -$60 ﹤0.01% 1070
2023
Q1
$877 Hold
14
﹤0.01% 1018
2022
Q4
$876 Buy
14
+2
+17% +$115 ﹤0.01% 957
2022
Q3
$1K Sell
12
-1
-8% -$55 ﹤0.01% 1029
2022
Q2
$1K Buy
13
+2
+18% +$110 ﹤0.01% 1057
2022
Q1
$1K Buy
+11
New +$635 ﹤0.01% 1119

Other funds holding PBH

Disciplined Investments's PBH Position: Q3 2023 in Review

Disciplined Investments sold out of Prestige Consumer Healthcare (PBH) in Q3 2023, closing a stake of 13 shares — an estimated $773 sold.

Disciplined Investments first reported a position in PBH in Q1 2022 and held it in 6 quarters. The position peaked at $1K in Q3 2022. 279 funds tracked by Wall St. Rank hold PBH as of Q3 2023.

  • Disciplined Investments reported no remaining Prestige Consumer Healthcare position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 13 Prestige Consumer Healthcare shares in Q3 2023, an estimated $773.
  • Disciplined Investments first reported a position in Prestige Consumer Healthcare in Q1 2022 and held it in 6 quarters.
  • Disciplined Investments's Prestige Consumer Healthcare position peaked at $1K in Q3 2022.
  • 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.